Table 1 Clinical characteristics of 11 patients with thrombosis combined with bleeding out of the 1137 patients at high risk for thrombosis.
Variables | Thrombosis with bleeding | Variables | Thrombosis with bleeding |
|---|---|---|---|
Physical characteristics of patients | Laboratory tests | ||
Gender, n (%) | Liver and kidney function at admission | ||
Male | 7 (63.64) | Albumin (g/L) | 35.78 ± 4.90 |
Female | 4 (36.36) | Creatinine (µmol/L) | 70.50 (58.90-85.55) |
Age (years) | 52.09 ± 20.04 | GFR(mL/min) | 69.54 ± 32.67 |
Weight (kg) | 62.27 ± 14.19 | CCr (mL/min) | 87.80 (40.30-119.80) |
Height (cm) | 162.82 ± 9.06 | Minimum platelet count (×109 /L) | 25(5–58) |
BMI, kg/m2 | 22.67 (19.63–24.22) | Diagnostic and treatment status | |
Patient health history | Bedridden > 72 h, n (%) | 5 (45.45) | |
Smoking history, n (%) | 3 (27.27) | Intravenous catheter placement, n (%) | 8 (72.73) |
History of alcohol consumption, n (%) | 1 (9.09) | Types of intravenous catheter, n (%) | |
History of diabetes, n (%) | 1 (9.09) | PICC | 6 (75.00) |
History of hypertension, n (%) | 0 (0.00) | CVC | 2 (25.00) |
History of coronary heart disease, n (%) | 0 (0.00) | Number of intravenous catheter lumens, n (%) | |
History of hyperlipidaemia, n (%) | 0 (0.00) | One | 5 (62.50) |
History of thrombosis, n (%) | 3 (27.27) | Two | 3 (37.50) |
Characteristics of the disease | Length of time the intravenous catheter (day) | 105.88 ± 91.00 | |
Type of haematological malignancies, n (%) | Erythropoietin, n (%) | 1 (9.09) | |
Leukaemia | 6 (54.55) | Parenteral nutrition, n (%) | 7 (63.64) |
Lymphomas | 3 (27.27) | Steroids, n (%) | 7 (63.64) |
Plasma cell tumour | 2 (18.18) | Immunomodulators, n (%) | 1 (9.09) |
Cell source of malignancies, n (%) | Sedatives, n (%) | 2 (18.18) | |
Myeloid | 6 (54.55) | Chemotherapy, n (%) | 8 (72.73) |
B-lineage | 5 (45.45) | Auto-HSCT, n (%) | 2 (18.18) |
Lower limb oedema, n (%) | 1 (9.09) | Patient outcomes | |
Septicaemia, n (%) | 4 (36.36) | Survival outcome, n (%) | |
Mediastinal involvement of lymph nodes, n (%) | 2 (18.18) | Survive | 10 (90.91) |
Extranodal diseases, n (%) | 0 (0.00) | Dead | 1 (9.09) |
Lung infection, n (%) | 8 (72.73) | Bleeding-thrombosis sequence, n (%) | |
CCI score | 4(3–5) | Thrombus priority | 5 (45.45) |
Caprini score | 6(6–7) | Bleeding priority | 4 (36.36) |
ISTH DIC score | 5.33 ± 1.58 | Bleeding-thrombosis at the same time | 2 (18.18) |
